This analysis describes what OpenAI's agreement states, permits, or reserves. It does not constitute a legal determination about enforceability. Regulatory applicability and practical outcomes may vary by jurisdiction, enforcement context, and individual circumstances. Read our methodology
The claim establishes that OpenAI's restrictions on gpt-5-thinking in this domain are not grounded in confirmed harm evidence but in a deliberate precautionary policy choice.
Interpretive note: The excerpt uses an ellipsis, suggesting text was omitted between the harm-evidence disclaimer and the precautionary conclusion. The canonical claim reflects only what the quoted language establishes.
Users of gpt-5-thinking are subject to precautionary restrictions in the biological harm domain even though OpenAI has stated it lacks definitive evidence of the specific risk those restrictions address.
How other platforms handle this
Datadog reserves the right, but does not assume the obligation, to investigate any violation of these Terms or misuse of the Site.
Pharmaceutical products
Offer eligibility is determined by Netflix at its sole discretion and we reserve the right to revoke an Offer and put your account on hold in the event that we determine you are not eligible.
Monitoring
OpenAI has changed this document before.
Receive same-day alerts, structured change summaries, and monitoring for up to 25 platforms.
"While we do not have definitive evidence that this model could meaningfully help a novice to create severe biological harm...we have chosen to take a precautionary approach.— Excerpt from OpenAI's OpenAI GPT-5 System Card
Buried in Robinhood's customer agreement is broad authority to close your positions, suspend your account, and force arbitration. Here is what it actually says.
Stripe's terms authorize fund reserves, payout withholding, and account termination. Here is what the agreement states and what business owners should review.
Compliance Governance Intelligence
Need to monitor specific governance provisions?
Compliance includes provision-level monitoring, governance timelines, regulatory mapping, and audit-ready analysis.
Built from archived source documents, structured governance mappings, and historical version tracking.
The claim establishes that OpenAI's restrictions on gpt-5-thinking in this domain are not grounded in confirmed harm evidence but in a deliberate precautionary policy choice.
Users of gpt-5-thinking are subject to precautionary restrictions in the biological harm domain even though OpenAI has stated it lacks definitive evidence of the specific risk those restrictions address.
ConductAtlas has identified this type of provision across 264 platforms. See the full comparison.
No. ConductAtlas is an independent monitoring service. We are not affiliated with, endorsed by, or sponsored by OpenAI.